Industry Insights: The Rise of Chronic Disease and What It Means for DME
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Industry Insights: The Rise of Chronic Disease and What It Means for DME
-
ナレーター：
-
著者：
概要
Chronic conditions like obesity, diabetes, COPD, and congestive heart failure are reshaping the U.S. healthcare system — and the demand for durable medical equipment along with it. In this episode of Industry Matters, VGM's Tyler Coulander and Alan Morris dig into the data behind America's growing chronic disease burden, what it means for DME providers navigating the shift from hospital-based to home-based care, and why demand for equipment and long-term patient support is more resilient than ever. They also tackle the big GLP-1 question: do drugs like Ozempic threaten CPAP and diabetes equipment markets, or do they actually open new doors? Tune in for a high-level look at the forces driving industry growth — and check out the VGM Industry Insights library for a deeper dive into the data.
Watch the video version on YouTube: https://youtu.be/rwZAg90E3d8